5-Methyl-1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 97%, 25g

Colonne HPLC NUCLEODUR® C8 Gravity 5 µm, 250 mm, 4,6 mm, 1 pièce(s)

1-(6-(2-Fluorophenoxy)pyridin-3-yl)ethanone, 95%, 100mg

2,6-Dichloropyridine-3-boronic Acid (contains varying amounts of Anhydride)5g

(4S,4'S)-1,1'-Bis(3-(tert-butyl)phenyl)-4,4'-dicyclohexyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

4-tert-Butyl-3-nitroaniline, 95+%, 1g

IMIDAZO[1,2-A]PYRAZINE-6-CARBOXYLIC ACID, 95.0%, 1g

4-(2-Aminoethyl)pyridine, 95.0%, 1g

Artesunate>98.0%(HPLC)(T)25g

ETHYL 2-(PYRIDAZIN-3-YL)ACETATE, 95.0%, 1g

Ethyl 5-oxo-5,6,7,8-tetrahydroquinoline-3-carboxylate, 97%, 250mg

3-(3-Fluoropyridin-4-yl)propanoic acid, 98%, 10g

3-Methyl-2-(3-oxo-2,3-dihydroisoxazol-5-yl)butanoic acid, 98%, 100mg